Friday, November 13, 2026

USD/EUR Bearish By 1% In The Last 21 Sessions

Automated market report from our archive (2020–2024), published before source-traceability. How we work

USD/EUR Bearish By 1% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.81% for the last 21 sessions. At 15:08 EST on Wednesday, 26 April, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 0.477% up from its 52-week low and 13.604% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.03%, a negative 0.08%, and a positive 0.48%, respectively.

USD/EUR's highest amplitude of average volatility was 0.38% (last week), 0.44% (last month), and 0.48% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd fails to kiss 1.1000 as USD index attempts recovery, US durable goods orders in focus. According to FXStreet on Monday, 24 April, "The EUR/USD pair has failed to test the psychological resistance of 1.1000 in the Tokyo session. "
  • Eur/usd price analysis: drops toward 1.1000 amid overbought RSI. According to FXStreet on Tuesday, 25 April, "Overall, EUR/USD pair is likely to decline in the short term but the bullish trend remains intact unless the quote stays beyond 1.0930.", "With this, the EUR/USD sellers are well set to test a two-week-old horizontal support zone of around 1.1000."
  • Eur/usd price analysis: Marches towards 1.1100 key psychological hurdle. According to FXStreet on Tuesday, 25 April, "However, a downward-sloping resistance line from early February 2023, close to 1.1085 at the latest, could join the nearly overbought conditions of the RSI (14) line to challenge the EUR/USD bulls past 1.1085.", "Following that, the monthly low of near 1.0788 gains the market's attention and give control to the EUR/USD bears."
  • Eur/usd eyes YTD high as US dollar weakens on lower US treasury yields. According to FXStreet on Monday, 24 April, "Data-wise, Germany's IFO Business Climate Conditions and Expectations improved compared to March's figures, spurring a jump in the EUR/USD pair towards the 1.1000 area."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com